Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
363 Results Found
HHS withdraws request for drug importation proposals
The Department of Health and Human Services withdrew requests for proposals on ways individuals could import prescription drugs from other countries where they are typically cheaper and companies could “reimport” insulin to sell at a lower price.
AHA expresses support for Drug-Price Transparency for Consumers Act
The AHA July 2 expressed support for the Drug-Price Transparency for Consumers Act of 2021 (S.2304).
Walmart Is Rolling Back Prices . . . This Time on Insulin
As patients and politicians continue searching for remedies to soaring insulin prices for diabetes patients, Walmart recently launched the first private-label version of the drug at less than half the price of brand-name versions.
AHA Voices Concern with Express Scripts’ New 340B Claims Reporting Policy
Amy Bricker
President
Express Scripts PBM
1 Express Way
Saint Louis, MO 63121
Dear Ms. Bricker:
AARP: Even in pandemic year, average price increase for common drugs more than twice inflation
Retail prices for 260 widely used brand-name prescription drugs last year increased by an average 2.9%, more than twice the general rate of inflation, according to a report released by AARP’s Public Policy Institute.
Campaign launches new ads urging lawmakers to hold ‘big Pharma’ accountable now
The Campaign for Sustainable Rx Pricing (CSRxP), of which the AHA is a founding member, launched new television and digital advertising encouraging policymakers to hold brand name drug companies accountable.
Drug pricing bills introduced in House and Senate
House Energy and Commerce Committee Chairman Frank Pallone Jr., D-NJ, re-introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) with other Democratic committee leaders.
Campaign encourages policymakers to lower prescription drug prices
The Campaign for Sustainable Rx Pricing launched a grassroots and digital advertising campaign urging policymakers to lower prescription drug prices.
New United Laboratory Policy Puts Profits ahead of Patient Care
The availability of swift, accurate and reliable diagnostic testing during the public health emergency has been extremely important.
AHA and ASHP urge FDA to protect patients from payer-mandated drug distribution model
The AHA and American Society of Health-System Pharmacists urged the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”